J&J Avoids Risky Opioid Trial With ‘Chump Change’ Ohio Deal

Bookmark
(Bloomberg) -- Johnson & Johnson agreed to pay more than $20 million to avoid the first federal trial in which it faced accusations of helping fuel the opioid epidemic by mishandling its painkillers.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.